Biologics

Published: Apr, 2015 | Pages: 325 | Publisher: RESEARCH IMPACT TECHNOLOGIES
Industry: Biotechnology | Report Format: Electronic (PDF)

This report on Biologics gives a market insight into products types including Monoclonal Antibodies, Blood & Blood Products, Vaccines, Insulin and Other, for both human and animal consumption. Market projections and estimates are illustrated by region and by type. The report serves as a guide to Biologics industry, covering more than 500 companies that are engaged in Biologics products and services. Major Contract Research Organizations, Research Institutes and Universities serving the Animal Biologics industry are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to Biologic products is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, and Rest of World with 116 exclusive graphically represented exhibits.

 Table of Content

I. SCOPE AND METHODOLOGY
II. REPORT SYNOPSIS
2.1 Biologics
Types of Biologics
Monoclonal Antibodies
Blood & Blood Products
Vaccines
Insulin
Growth Hormones
Human Biologics
Animal Biologics
History of Biologics
Exhibit 1. Segmentation of Global Biologics Market - by Type and by Application
2.2 Global Market Analysis
Exhibit 2. Biologics – Global Value Market Estimations and Predictions (2005-2020) in US$ Million
Exhibit 3. List of Major Global Biologics Companies
III. MARKET DYNAMICS
3.1. Global Biologics Market
Exhibit 4. Biologics - Global Value Market Estimations and Predictions (2005-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 5. Biologics - Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.2 North American Biologics Market
Exhibit 6. Biologics - North American Value Market Estimations and Predictions (2005-2020) by Countries for United States, Canadian and Mexico in US$ Million
Exhibit 7. Biologics - North American Value Market Shares (2010, 2015 & 2020) by Countries for United States, Canadian and Mexico
3.2 (I) US Biologics Market
3.2 (II) Canadian Biologics Market
3.2 (III) Mexican Biologics Market
Exhibit 8. List of Major North American Biologics Companies
3.3 European Biologics Market
Exhibit 9. Biologics - European Value Market Estimations and Predictions (2005-2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe in US$ Million
Exhibit 10. Biologics - European Value Market Shares (2010, 2015 & 2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe
3.3 (I) German Biologics Market
3.3 (II) UK Biologics Market
3.3 (III) French Biologics Market
3.3 (IV) Dutch Biologics Market
3.3 (V) Spanish Biologics Market
3.3 (VI) Russian Biologics Market
Exhibit 11. List of Major European Biologics Companies
3.4 Asia-Pacific Biologics Market
Exhibit 12. Biologics - Asia-Pacific Value Market Estimations and Predictions (2005-2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 13. Biologics - Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific
3.4 (I) Japanese Biologics Market
3.4 (II) Australian Biologics Market
3.4 (III) Indian Biologics Market
3.4 (IV) Chinese Biologics Market
3.4 (V) South Korean Biologics Market
Exhibit 14. List of Major Asia-Pacific Biologics Companies
3.5 Rest of World Biologics Market
Exhibit 15. Biologics - Rest of World Value Market Estimations and Predictions (2005-2020) by Countries for Brazil, South Africa, Israel and Other Countries in US$ Million
Exhibit 16. Biologics - Rest of World Value Market Estimations and Predictions (2010, 2015 & 2020) by Countries for Brazil, South Africa, Israel and Other Countries
3.5 (I) Brazilian Biologics Market
3.5 (II) South African Biologics Market
3.5 (III) Israeli Biologics Market
Exhibit 17. List of Major Rest of World Biologics Companies
3.5 Major Animal Biologics Company Profiles
Abbott Laboratories (USA)
Pfizer Animal Health (USA)
Sanofi (France)
Novartis Animal Health (Switzerland)
More….
3.6 Significant Market Developments
Schering-Plough Corporation acquired Organon BioSciences
Novartis Animal Health Completes Acquisition of Lifetech Animal Health Co. Ltd. in Japan
Pfizer Buys Embrex For $155 Million
Virbac acquires GSK's Animal Health Business
Sanofi launches major new biologics initiative
Pfizer Completes Acquisition of King Pharmaceuticals, Inc.
PRIONICS Acquires Pfizer Animal Health's Diagnostic Products
Hemispherx Biopharma Acquires New Technology to Advance DNA-Based Vaccine Production
More………………………………….
3.7 Biologics - Analysis by Type
Exhibit 18. Biologics – Global Value Market Estimations and Predictions (2005-2020) by Type for Monoclonal Antibodies, Blood & Blood Products, Vaccines, Insulin and Other in US$ Million
Exhibit 19. Biologics– Global Value Market Shares (2010, 2015 &2020) by Type for Monoclonal Antibodies, Blood & Blood Products, Vaccines, Insulin and Other
3.7.1 Monoclonal Antibodies
3.7.1.1 Global Monoclonal Antibodies Market
Exhibit 20. Monoclonal Antibodies - Global Value Market Estimations and Predictions (2005-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 21. Monoclonal Antibodies - Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.7.1.2 North American Monoclonal Antibodies Market
Exhibit 22. Monoclonal Antibodies - North American Value Market Estimations and Predictions (2005-2020) by Countries for United States, Canadian and Mexico in US$ Million
Exhibit 23. Monoclonal Antibodies - North American Value Market Shares (2010, 2015 & 2020) by Countries for United States, Canadian and Mexico
3.7.1.2 (I) US Monoclonal Antibodies Market
3.7.1.2 (II) Canadian Monoclonal Antibodies Market
3.7.1.2 (III) Mexican Monoclonal Antibodies Market
Exhibit 24. List of Major North American Monoclonal Antibodies Companies
3.7.1.3 European Monoclonal Antibodies Market
Exhibit 25. Monoclonal Antibodies - European Value Market Estimations and Predictions (2005-2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe in US$ Million
Exhibit 26. Monoclonal Antibodies - European Value Market Shares (2010, 2015 & 2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe
3.7.1.3 (I) German Monoclonal Antibodies Market
3.7.1.3 (II) UK Monoclonal Antibodies Market
3.7.1.3 (III) French Monoclonal Antibodies Market
3.7.1.3 (IV) Dutch Monoclonal Antibodies Market
3.7.1.3 (V) Spanish Monoclonal Antibodies Market
3.7.1.3 (VI) Russian Monoclonal Antibodies Market
Exhibit 27. List of Major European Monoclonal Antibodies Companies
3.7.1.4 Asia-Pacific Monoclonal Antibodies Market
Exhibit 28. Monoclonal Antibodies - Asia-Pacific Value Market Estimations and Predictions (2005-2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 29. Monoclonal Antibodies - Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific
3.7.1.4 (I) Japanese Monoclonal Antibodies Market
3.7.1.4 (II) Australian Monoclonal Antibodies Market
3.7.1.4 (III) Indian Monoclonal Antibodies Market
3.7.1.4 (IV) Chinese Monoclonal Antibodies Market
3.7.1.4 (V) South Korean Monoclonal Antibodies Market
Exhibit 30. List of Major Asia-Pacific Monoclonal Antibodies Companies
Rest of World Monoclonal Antibodies Market
Exhibit 31. Monoclonal Antibodies - Rest of World Value Market Estimations and Predictions (2005-2020) by Countries for Brazil, South Africa, Israel and Other Countries in US$ Million
Exhibit 32. Monoclonal Antibodies - Rest of World Value Market Shares (2010, 2015 & 2020) by Countries for Brazil, South Africa, Israel and Other Countries
3.7.1.5 (I) Brazilian Monoclonal Antibodies Market
3.7.1.5 (II) South African Monoclonal Antibodies Market
3.7.1.5 (III) Israeli Monoclonal Antibodies Market
Exhibit 33. List of Major Rest of World Monoclonal Antibodies Companies
3.7.2 Blood & Blood Products Marke
3.7.2.1 Global Blood & Blood Products Market
Exhibit 34. Blood & Blood Products - Global Value Market Estimations and Predictions (2005-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 35. Blood & Blood Products - Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.7.2.2 North American Blood & Blood Products Market
Exhibit 36. Blood & Blood Products - North American Value Market Estimations and Predictions (2005-2020) by Countries for United States, Canadian and Mexico in US$ Million
Exhibit 37. Blood & Blood Products - North American Value Market Shares (2010, 2015 & 2020) by Countries for United States, Canadian and Mexico
3.7.2.2 (I) US Blood & Blood Products Market
3.7.2.2 (II) Canadian Blood & Blood Products Market
3.7.2.2 (III) Mexican Blood & Blood Products Market
Exhibit 38. List of Major North American Blood & Blood Products Companies
3.7.2.3 European Blood & Blood Products Market
Exhibit 39. Blood & Blood Products - European Value Market Estimations and Predictions (2005-2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe in US$ Million
Exhibit 40. Blood & Blood Products - European Value Market Shares (2010, 2015 & 2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe
3.7.2.3 (I) German Blood & Blood Products Market
3.7.2.3 (II) UK Blood & Blood Products Market
3.7.2.3 (III) French Blood & Blood Products Market
3.7.2.3 (IV) Dutch Blood & Blood Products Market
3.7.2.3 (V) Spanish Blood & Blood Products Market
3.7.2.3 (VI) Russian Blood & Blood Products Market
Exhibit 41. List of Major European Blood & Blood Products Companies
3.7.2.4 Asia-Pacific Blood & Blood Products Market
Exhibit 42. Blood & Blood Products - Asia-Pacific Value Market Estimations and Predictions (2005-2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 43. Blood & Blood Products - Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific
3.7.2.4 (I) Japanese Blood & Blood Products Market
3.7.2.4 (II) Australian Blood & Blood Products Market
3.7.2.4 (III) Indian Blood & Blood Products Market
3.7.2.4 (IV) Chinese Blood & Blood Products Market
3.7.2.4 (V) South Korean Blood & Blood Products Market
Exhibit 44. List of Major Asia-Pacific Blood & Blood Products Companies
3.7.2.5 Rest of World Blood & Blood Products Market
Exhibit 45. Blood & Blood Products - Rest of World Value Market Estimations and Predictions (2005-2020) by Countries for Brazil, South Africa, Israel and Other Countries in US$ Million
Exhibit 46. Blood & Blood Products - Rest of World Value Market Shares (2010, 2015 & 2020) by Countries for Brazil, South Africa, Israel and Other Countries
3.7.2.5 (I) Brazilian Blood & Blood Products Market
3.7.2.5 (II) South Africa Blood & Blood Products Market
3.7.2.5 (III) Israeli Blood & Blood Products Market
Exhibit 47. List of Major Rest of World Blood & Blood Products Companies
3.7.3 Vaccines
3.7.3.1 Global Vaccines Market
Exhibit 48. Vaccines - Global Value Market Estimations and Predictions (2005-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 49. Vaccines - Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.7.3.2 North American Vaccines Market
Exhibit 50. Vaccines - North American Value Market Estimations and Predictions (2005-2020) by Countries for United States, Canadian and Mexico in US$ Million
Exhibit 51. Vaccines - North American Value Market Shares (2010, 2015 & 2020) by Countries for United States, Canadian and Mexico
3.7.3.2 (I) US Vaccines Market
3.7.3.2 (II) Canadian Vaccines Market
3.7.3.2 (III) Mexican Vaccines Market
Exhibit 52. List of Major North American Vaccines Companies
3.7.3.3 European Vaccines Market
Exhibit 53. Vaccines - European Value Market Estimations and Predictions (2005-2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe in US$ Million
Exhibit 54. Vaccines - European Value Market Shares (2010, 2015 & 2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe
3.7.3.3 (I) German Vaccines Market
3.7.3.3 (II) UK Vaccines Market
3.7.3.3 (III) French Vaccines Market
3.7.3.3 (IV) Dutch Vaccines Market
3.7.3.3 (V) Spanish Vaccines Market
3.7.3.3 (VI) Russian Vaccines Market
Exhibit 55. List of Major European Vaccines Companies
3.7.3.4 Asia-Pacific Vaccines Market
Exhibit 56. Vaccines - Asia-Pacific Value Market Estimations and Predictions (2005-2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 57. Vaccines - Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific
3.7.3.4 (I) Japanese Vaccines Market
3.7.3.4 (II) Australian Vaccines Market
3.7.3.4 (III) Indian Vaccines Market
3.7.3.4 (IV) Chinese Vaccines Market
3.7.3.4 (V) South Korean Vaccines Market
Exhibit 58. List of Major Asia-Pacific Vaccines Companies
3.7.3.5 Rest of World Vaccines Market
Exhibit 59. Vaccines - Rest of World Value Market Estimations and Predictions (2005-2020) by Countries for Brazil, South Africa, Israel and Other Countries in US$ Million
Exhibit 60. Vaccines - Rest of World Value Market Shares (2010, 2015 & 2020) by Countries for Brazil, South Africa, Israel and Other Countries
3.7.3.5 (I) Brazilian Vaccines Market
3.7.3.5 (II) South Africa Vaccines Market
3.7.3.5 (III) Israeli Vaccines Market
Exhibit 61. List of Major Rest of World Vaccines Companies
3.7.4 Insulin
3.7.4.1 Global Insulin Market
Exhibit 62. Insulin - Global Value Market Estimations and Predictions (2005-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 63. Insulin - Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.7.4.2 North American Insulin Market
Exhibit 64. Insulin - North American Value Market Estimations and Predictions (2005-2020) by Countries for United States, Canadian and Mexico in US$ Million
Exhibit 65. Insulin - North American Value Market Shares (2010, 2015 & 2020) by Countries for United States, Canadian and Mexico
3.7.4.2 (I) US Insulin Market
3.7.4.2 (II) Canadian Insulin Market
3.7.4.2 (III) Mexican Insulin Market
Exhibit 66. List of Major North American Insulin Companies
3.7.4.3 European Insulin Market
Exhibit 67. Insulin - European Value Market Estimations and Predictions (2005-2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe in US$ Million
Exhibit 68. Insulin - European Value Market Shares (2010, 2015 & 2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe
3.7.4.3 (I) German Insulin Market
3.7.4.3 (II) UK Insulin Market
3.7.4.3 (III) French Insulin Market
3.7.4.3 (IV)Dutch Insulin Market
3.7.4.3 (V) Spanish Insulin Market
3.7.4.3 (VI) Russian Insulin Market
Exhibit 69. List of Major European Insulin Companies
3.7.4.4 Asia-Pacific Insulin Market
Exhibit 70. Insulin - Asia-Pacific Value Market Estimations and Predictions (2005-2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 71. Insulin - Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific
3.7.4.4 (I) Japanese Insulin Market
3.7.4.4 (II) Australian Insulin Market
3.7.4.4 (III) Indian Insulin Market
3.7.4.4 (IV) Chinese Insulin Market
3.7.4.4 (V) South Korean Insulin Market
Exhibit 72. List of Major Asia-Pacific Insulin Companies
3.7.4.5 Rest of World Insulin Market
Exhibit 73. Insulin - Rest of World Value Market Estimations and Predictions (2005-2020) by Countries for Brazil, South Africa, Israel and Other Countries in US$ Million
Exhibit 74. Insulin - Rest of World Value Market Shares (2010, 2015 & 2020) by Countries for Brazil, South Africa, Israel and Other Countries
3.7.4.5 (I) Brazilian Insulin Market
3.7.4.5 (II) South African Insulin Market
3.7.4.5 (III) Israeli Insulin Market
Exhibit 75. List of Major Rest of World Insulin Companies
3.7.5 Other Biologics
3.7.5.1 Global Other Biologics Market
Exhibit 76. Other Biologics - Global Value Market Estimations and Predictions (2005-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 77. Other Biologics - Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.7.5.2 North American Other Biologics Market
Exhibit 78. Other Biologics - North American Value Market Estimations and Predictions (2005-2020) by Countries for United States, Canadian and Mexico in US$ Million
Exhibit 79. Other Biologics - North American Value Market Shares (2010, 2015 & 2020) by Countries for United States, Canadian and Mexico
3.7.5.3 European Other Biologics Market
Exhibit 80. Other Biologics - European Value Market Estimations and Predictions (2005-2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe in US$ Million
Exhibit 81. Other Biologic - European Value Market Shares (2010, 2015 & 2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe
3.7.5.4 Asia-Pacific Other Biologics Market
Exhibit 82. Other Biologics - Asia-Pacific Value Market Estimations and Predictions (2005-2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 83. Other Biologics - Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific
3.7.5.5 Rest of World Other Biologics Market
Exhibit 84. Other Biologics - Rest of World Value Market Estimations and Predictions (2005-2020) by Countries for Brazil, South Africa, Israel and Other Countries in US$ Million
Exhibit 85. Other Biologics - Rest of World Value Market Shares (2010, 2015 & 2020) by Countries for Brazil, South Africa, Israel and Other Countries
3.8 By Application
Exhibit 86. Biologics– Global Value Market Estimations and Predictions (2005-2020) by Application for Human and Animal in US$ Million
Exhibit 87. Biologics– Global Value Market Shares (2010, 2015 & 2020) by Application for Human and Animal
3.8.1 Human Biologics
3.8.1.1 Global Human Biologics Market
Exhibit 88. Human Biologics - Global Value Market Estimations and Predictions (2005-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 89. Human Biologics - Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.8.1.2 North American Human Biologics Market
Exhibit 90. Human Biologics - North American Value Market Estimations and Predictions (2005-2020) by Countries for United States, Canadian and Mexico in US$ Million
Exhibit 91. Human Biologics - North American Value Market Shares (2010, 2015 & 2020) by Countries for United States, Canadian and Mexico
3.8.1.2 (I) US Human Biologics Market
3.8.1.2 (II) Canadian Human Biologics Market
3.8.1.2 (III) Mexican Human Biologics Market
Exhibit 92. List of Major North American Human Biologics Companies
3.8.1.3 European Human Biologics Market
Exhibit 93. Human Biologics - European Value Market Estimations and Predictions (2005-2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe in US$ Million
Exhibit 94. Human Biologics - European Value Market Shares (2010, 2015 & 2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe
3.8.1.3 (I) German Human Biologics Market
3.8.1.3 (II) UK Human Biologics Market
3.8.1.3 (III) French Human Biologics Market
3.8.1.3 (IV) Dutch Human Biologics Market
3.8.1.3 (V) Spanish Human Biologics Market
3.8.1.3 (VI) Russian Human Biologics Market
Exhibit 95. List of Major European Human Biologics Companies
3.8.1.4 Asia-Pacific Human Biologics Market
Exhibit 96. Human Biologics - Asia-Pacific Value Market Estimations and Predictions (2005-2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 97. Human Biologics - Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific
3.8.1.4 (I) Japanese Human Biologics Market
3.8.1.4 (II) Australian Human Biologics Market
3.8.1.4 (III) Indian Human Biologics Market
3.8.1.4 (IV) Chinese Human Biologics Market
3.8.1.4 (V) South Korean Human Biologics Market
Exhibit 98. List of Major Asia-Pacific Human Biologics Companies
3.8.1.5 Rest of World Human Biologics Market
Exhibit 99. Human Biologics - Rest of World Value Market Estimations and Predictions (2005-2020) by Countries for Brazil, South Africa, Israel and Other Countries in US$ Million
Exhibit 100. Human Biologics - Rest of World Value Market Shares (2010, 2015 & 2020) by Countries for Brazil, South Africa, Israel and Other Countries
3.8.1.5 (I) Brazilian Human Biologics Market
3.8.1.5 (II) South African Human Biologics Market
3.8.1.5 (III) Israeli Human Biologics Market
Exhibit 101. List of Major Rest of World Human Biologics Companies
3.8.2 Animal Biologics
3.8.2.1 Global Animal Biologics Market
Exhibit 102. Animal Biologics - Global Value Market Estimations and Predictions (2005-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Exhibit 103. Animal Biologics - Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.8.2.2 North American Animal Biologics Market
Exhibit 104. Animal Biologics - North American Value Market Estimations and Predictions (2005-2020) by Countries for United States, Canadian and Mexico in US$ Million
Exhibit 105. Animal Biologics - North American Value Market Shares (2010, 2015 & 2020) by Countries for United States, Canadian and Mexico
3.8.2.2 (I) US Animal Biologics Market
3.8.2.2 (II) Canadian Animal Biologics Market
3.8.2.2 (III) Mexican Animal Biologics Market
Exhibit 106. List of Major North American Animal Biologics Companies
3.8.2.3 European Animal Biologics Market
Exhibit 107. Animal Biologics - European Value Market Estimations and Predictions (2005-2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe in US$ Million
Exhibit 108. Animal Biologics - European Value Market Shares (2010, 2015 & 2020) by Countries for Germany, UK, France, The Netherlands, Spain, Russia and Rest of Europe
3.8.2.3 (I) German Animal Biologics Market
3.8.2.3 (II) UK Animal Biologics Market
3.8.2.3 (III) French Animal Biologics Market
3.8.2.3 (IV) Dutch Animal Biologics Market
3.8.2.3 (V) Spanish Animal Biologics Market
3.8.2.3 (VI) Russian Animal Biologics Market
Exhibit 109. List of Major European Animal Biologics Companies
3.8.2.4 Asia-Pacific Animal Biologics Market
Exhibit 110. Animal Biologics - Asia-Pacific Value Market Estimations and Predictions (2005-2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 111. Animal Biologics - Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Countries for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific
3.8.2.4 (I) Japanese Animal Biologics Market
3.8.2.4 (II) Australian Animal Biologics Market
3.8.2.4 (III) Indian Animal Biologics Market
3.8.2.4 (IV) Chinese Animal Biologics Market
3.8.2.4 (VI) South Korean Animal Biologics Market
Exhibit 112. List of Major Asia-Pacific Animal Biologics Companies
3.8.2.5 Rest of World Animal Biologics Market
Exhibit 113. Animal Biologics - Rest of World Value Market Estimations and Predictions (2005-2020) by Countries for Brazil, South Africa, Israel and Other Countries in US$ Million
Exhibit 114. Animal Biologics - Rest of World Value Market Shares (2010, 2015 & 2020) by Countries for Brazil, South Africa, Israel and Other Countries
3.8.2.5 (I) Brazilian Animal Biologics Market
3.8.2.5 (II) South African Animal Biologics Market
3.8.2.5 (III) Israeli Animal Biologics Market
Exhibit 115. List of Major Rest of World Animal Biologics Companies
3.9 Biologics – Market Outlook
4. PRODUCT/TECHNOLOGY RESEARCH
1. Introduction
Biopharmaceuticals
Biologics
Difference between Biologics and Conventional Pharmaceuticals
Manufacturing Procedure
Therapeutic Targets
Product Attribution
Biosimilars
Difference between Generic Drugs and Biosimilars
Advantages of Biologics
Types of Bioloigcs
Exhibit 116. List of Top 10 Biologics and sales
4.2 Blood & Blood Products
Blood Components
Plasma Based Products
Stem Cells
Therapeutic Applications (Human and Animal)
Production/ Extraction Procedures
Cord Blood Banks
4.3 Monoclonal Antibodies
Production/Extraction Process
Therapeutic Applications
4.4 Vaccines
Production Technology
Human Vaccines and Animal Vaccines
Types of Vaccines
4.5 Insulin
Production Process
Growth Hormones
4.6 Applications of Biologics
Biologics for Human Purpose
Biologics for Animal Purpose
Rules and Regulations – Biologics
4.7 Biologics - Research Briefs
5. CORPORATE DIRECTORY
6. PATENTS INFORMATION